Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.

TitleAllelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma.
Publication TypeJournal Article
Year of Publication2001
AuthorsKulke MH, Odze RD, Thakore KS, Thomas G, Wang H, Loda M, Eng C
JournalBr J Cancer
Volume84
Issue6
Pagination748-53
Date Published2001 Mar 23
ISSN0007-0920
KeywordsAdenocarcinoma, Adult, Aged, Aged, 80 and over, Alleles, Barrett Esophagus, Chromosomes, Human, Pair 10, Female, Genes, Tumor Suppressor, Humans, Loss of Heterozygosity, Male, Middle Aged, Phosphoric Monoester Hydrolases, PTEN Phosphohydrolase, Tumor Suppressor Proteins
Abstract

PTEN is a putative tumour suppressor gene located on chromosome band 10q23. Mutations in PTEN have been identified in numerous human malignancies, including cancers of the brain, endometrium, ovary, and prostate. In this study, we screened 80 Barrett's oesophagus-associated adenocarcinomas (BOAd) for loss of heterozygosity (LOH) at 10q23, using the microsatellite markers D10S541, D10S219, and D10S551. Tumours demonstrating LOH were then screened for the presence or absence of PTEN mutations. LOH at one or more loci was identified in 17/80 (21%) cases. In none of these cases did we detect mutations in PTEN. The presence of LOH did not correlate with patient age, tumour stage, degree of differentiation, presence of perineural or vascular invasion, or overall survival. We conclude that LOH at chromosome 10q23 is uncommon in BOAd, is not associated with mutations in the PTEN tumour suppressor gene, and does not correlate with the clinical or pathologic features of these tumours. It is possible that PTEN is inactivated through other mechanisms in BOAd.

DOI10.1054/bjoc.2000.1660
Alternate JournalBr J Cancer
PubMed ID11259087
PubMed Central IDPMC2363812
Related Faculty: 
Massimo Loda, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700